BACKGROUND: Despite the publication and dissemination of the Advanced Cardiac Life Support guidelines, variability in the use of drugs during resuscitation from out-of-hospital cardiac arrest may exist between different Emergency Medical Services throughout North America. The purpose of this study was to characterize the use of such drugs and evaluate their relationship to cardiac arrest outcomes. METHODS AND RESULTS: The Resuscitation Outcomes Consortium Registry-Cardiac Arrest collects out-of-hospital cardiac arrest data from 264 Emergency Medical Services agencies in 11 geographical locations in the U.S. and Canada. Multivariable logistic regression was used to assess the association between drug use, characteristics of the cardiac arrest and a pulse at emergency department arrival and survival to discharge. A total of 16,221 out-of-hospital cardiac arrests were attended by 74 Emergency Medical Services agencies. There was a considerable variability in the administration of amiodarone and lidocaine for the treatment of shock resistant ventricular tachycardia/ventricular fibrillation. For non-shockable rhythms, atropine use ranged from 29 to 95% and sodium bicarbonate use ranged from 0.2 to 73% across agencies in the 89% of agencies that used the drug. Epinephrine use ranged from 57 to 98% within agencies. Neither lidocaine nor amiodarone was associated with a survival benefit while there was an inverse relationship between the administration of epinephrine, atropine and sodium bicarbonate and survival to hospital discharge. CONCLUSIONS: There is considerable variability among Emergency Medical Services agencies in their use of pharmacological therapy for out-of-hospital cardiac arrests which may be resolved by performing large randomized trials examining effects on survival.
BACKGROUND: Despite the publication and dissemination of the Advanced Cardiac Life Support guidelines, variability in the use of drugs during resuscitation from out-of-hospital cardiac arrest may exist between different Emergency Medical Services throughout North America. The purpose of this study was to characterize the use of such drugs and evaluate their relationship to cardiac arrest outcomes. METHODS AND RESULTS: The Resuscitation Outcomes Consortium Registry-Cardiac Arrest collects out-of-hospital cardiac arrest data from 264 Emergency Medical Services agencies in 11 geographical locations in the U.S. and Canada. Multivariable logistic regression was used to assess the association between drug use, characteristics of the cardiac arrest and a pulse at emergency department arrival and survival to discharge. A total of 16,221 out-of-hospital cardiac arrests were attended by 74 Emergency Medical Services agencies. There was a considerable variability in the administration of amiodarone and lidocaine for the treatment of shock resistant ventricular tachycardia/ventricular fibrillation. For non-shockable rhythms, atropine use ranged from 29 to 95% and sodium bicarbonate use ranged from 0.2 to 73% across agencies in the 89% of agencies that used the drug. Epinephrine use ranged from 57 to 98% within agencies. Neither lidocaine nor amiodarone was associated with a survival benefit while there was an inverse relationship between the administration of epinephrine, atropine and sodium bicarbonate and survival to hospital discharge. CONCLUSIONS: There is considerable variability among Emergency Medical Services agencies in their use of pharmacological therapy for out-of-hospital cardiac arrests which may be resolved by performing large randomized trials examining effects on survival.
Authors: Paul Dorian; Dan Cass; Brian Schwartz; Richard Cooper; Robert Gelaznikas; Aiala Barr Journal: N Engl J Med Date: 2002-03-21 Impact factor: 91.245
Authors: C G Brown; D R Martin; P E Pepe; H Stueven; R O Cummins; E Gonzalez; M Jastremski Journal: N Engl J Med Date: 1992-10-08 Impact factor: 91.245
Authors: I G Stiell; P C Hebert; B N Weitzman; G A Wells; S Raman; R M Stark; L A Higginson; J Ahuja; G E Dickinson Journal: N Engl J Med Date: 1992-10-08 Impact factor: 91.245
Authors: J Lipman; W Wilson; S Kobilski; J Scribante; C Lee; P Kraus; J Cooper; J Barr; D Moyes Journal: Anaesth Intensive Care Date: 1993-04 Impact factor: 1.669
Authors: Peter J Kudenchuk; Siobhan P Brown; Mohamud Daya; Laurie J Morrison; Brian E Grunau; Tom Rea; Tom Aufderheide; Judy Powell; Brian Leroux; Christian Vaillancourt; Jonathan Larsen; Lynn Wittwer; M Riccardo Colella; Shannon W Stephens; Mark Gamber; Debra Egan; Paul Dorian Journal: Am Heart J Date: 2014-03-01 Impact factor: 4.749
Authors: Ian R Drennan; Erin Case; P Richard Verbeek; Joshua C Reynolds; Zachary D Goldberger; Jamie Jasti; Mark Charleston; Heather Herren; Ahamed H Idris; Paul R Leslie; Michael A Austin; Yan Xiong; Robert H Schmicker; Laurie J Morrison Journal: Resuscitation Date: 2016-12-05 Impact factor: 5.262
Authors: Chika Nishiyama; Siobhan P Brown; Susanne May; Taku Iwami; Rudolph W Koster; Stefanie G Beesems; Markku Kuisma; Ari Salo; Ian Jacobs; Judith Finn; Fritz Sterz; Alexander Nürnberger; Karen Smith; Laurie Morrison; Theresa M Olasveengen; Clifton W Callaway; Sang Do Shin; Jan-Thorsten Gräsner; Mohamud Daya; Matthew Huei-Ming Ma; Johan Herlitz; Anneli Strömsöe; Tom P Aufderheide; Siobhán Masterson; Henry Wang; Jim Christenson; Ian Stiell; Dan Davis; Ella Huszti; Graham Nichol Journal: Resuscitation Date: 2014-07-08 Impact factor: 5.262
Authors: Shin Ahn; Youn-Jung Kim; Chang Hwan Sohn; Dong Woo Seo; Kyoung Soo Lim; Michael W Donnino; Won Young Kim Journal: J Thorac Dis Date: 2018-04 Impact factor: 2.895
Authors: Hyuk Jun Yang; Gi Woon Kim; Hyun Kim; Jin Seong Cho; Tai Ho Rho; Han Deok Yoon; Mi Jin Lee Journal: J Korean Med Sci Date: 2014-12-23 Impact factor: 2.153
Authors: Mohammed A Al-Mulhim; Mohammed S Alshahrani; Laila Perlas Asonto; Ahmad Abdulhady; Talal M Almutairi; Mariam Hajji; Mohammed A Alrubaish; Khalid N Almulhim; Mariam H Al-Sulaiman; Layla B Al-Qahtani Journal: J Int Med Res Date: 2019-07-16 Impact factor: 1.671